The artificial tears are the lubricant eye drops, which are used for the treatment of dryness and irritation mostly caused due to deficiency of tear production. These artificial tears are formulated to initiate natural tears and treats various eye disorders such as allergy, infection and protection from UV and blue light. It was also used for moisturizing the contact lens.ย 

๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :

The key players operating in the global market include AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

๐Š๐„๐˜ ๐…๐ˆ๐๐ƒ๐ˆ๐๐†๐’ ๐Ž๐… ๐“๐‡๐„ ๐’๐“๐”๐ƒ๐˜

  • By product type, the solution segment was the highest contributor to the market in 2020.
  • By container type, the plastic multi-dose container segment was the highest contributor to the market in 2020.
  • By formulation, the preservative free segment was the highest contributor to the market in 2020.
  • By application, the dry eye syndrome segment was the highest contributor to the market in 2020.
  • By distribution channel, the Drug Store & Retail Pharmacies segment dominated the market in 2020 and is expected to continue this trend throughout the review period.
  • By region, North America garnered largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the review period.

๐…๐จ๐ซ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ

The development of effective OTC artificial tears has become essential, owing to increase in incidence of dry eye syndrome and eye surgeries. OTC artificial tears are administered in different dosage forms such as solution, ointment, emulsion, gel, spray solution, and suspension depending on the indication. Market players are focusing on the development of novel approaches for the development of OTC artificial tears over the years, including small molecule, biologic, and recombinant technologies. Increase in investment in R&D in the development of new artificial tears for treatment of dry eye syndrome, allergies, and UV and blue light protection, and a rise in geriatric population is anticipated to drive the growth of the OTC artificial tears market. In addition, increase in the awareness of dry eye syndrome among population supplement the market growth.ย 

The OTC artificial tears market is segmented into product type, container type, formulation, application, distribution channel and region. On the basis of product type, the market is divided into solution, ointment, emulsion, gel, spray solution and suspension. The solution segment dominated the market in 2020, due to rise in demand for product available in the form of eye drops and increase in patient acceptability. 

๐—š๐—ฒ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐—ฒ๐—ฑ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

Drug Abuse Testing Market

Sports Medicine Devices Marketย 

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

Leave a comment

Your email address will not be published. Required fields are marked *